Employee Benefit Plans (Tables)
|
6 Months Ended |
Jun. 28, 2026 |
|---|
| Employee Benefit and Share-Based Payment Arrangement, Noncash Expense [Abstract] |
|
| Schedule of Shares Available for Grant |
The following table sets forth the available shares for grants as of June 28, 2026:
| | | | | | | Number of Shares | | (In thousands) | Shares available for grants as of December 31, 2025 | 4,409 | | | Additional authorized shares | 4,200 | | | Granted | (5,949) | | | Forfeited / expired / cancelled | 209 | | | | Shares available for grants as of June 28, 2026 | 2,869 | |
|
| Schedule of Stock Option Activity |
Stock option activity during the six months ended June 28, 2026 was as follows: | | | | | | | | | | | | | Number of Shares | | Weighted Average Exercise Price Per Share | | (In thousands) | | (In dollars) | Outstanding as of December 31, 2025 | 275 | | | $ | 14.10 | | | Granted | — | | | $ | — | | | Exercised | — | | | $ | — | | | Expired / cancelled | — | | | $ | — | | Outstanding as of June 28, 2026 | 275 | | | $ | 14.10 | | Vested and exercisable as of June 28, 2026 | 275 | | | $ | 14.10 | |
|
| Schedule of RSU Activity |
RSU activity, exclusive of PSU activity, during the six months ended June 28, 2026 was as follows:
| | | | | | | | | | | | | Number of Shares | | Weighted Average Grant Date Fair Value Per Share | | (In thousands) | | (In dollars) | Outstanding as of December 31, 2025 | 6,481 | | | $ | 9.99 | | | Granted | 3,062 | | | $ | 13.81 | | | Vested | (2,681) | | | $ | 10.58 | | | Forfeited / cancelled | (206) | | | $ | 13.06 | | Outstanding as of June 28, 2026 | 6,656 | | | $ | 11.41 | |
|
| Schedule of PSU Activity |
PSU activity during the six months ended June 28, 2026 was as follows:
| | | | | | | | | | | |
| Number of Shares | | Weighted Average Grant Date Fair Value Per Share | | (In thousands) | | (In dollars) | Outstanding as of December 31, 2025 | 2,970 | | | $ | 10.56 | | | Granted | 2,887 | | | $ | 11.95 | | | Vested | (1,934) | | | $ | 10.29 | | | Forfeited / cancelled | (3) | | | $ | 8.28 | | Outstanding as of June 28, 2026 | 3,920 | | | $ | 11.72 | |
|
| Schedule of Stock-Based Compensation Expense |
The following table sets forth the stock-based compensation expense by line item on the unaudited condensed consolidated statements of operations and comprehensive income (loss):
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 28,
2026 | | June 29,
2025 | | June 28,
2026 | | June 29,
2025 | | (In thousands) | | Cost of revenue | $ | 1,136 | | | $ | 885 | | | $ | 2,510 | | | $ | 2,002 | | | Research and development | 6,730 | | | 4,500 | | | 13,901 | | | 8,400 | | | Sales and marketing | 2,896 | | | 2,079 | | | 6,070 | | | 5,152 | | | General and administrative | 10,948 | | | 7,519 | | | 18,963 | | | 16,441 | | | Stock-based compensation, net of amounts capitalized | $ | 21,710 | | | $ | 14,983 | | | $ | 41,444 | | | $ | 31,995 | | | Capitalized stock-based compensation | 472 | | | 267 | | | 778 | | | 868 | | | Total stock-based compensation | $ | 22,182 | | | $ | 15,250 | | | $ | 42,222 | | | $ | 32,863 | |
|